ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - January 1920

Decade

Year

Issue

October 2022, Vol 158, No. 10, Pages 1101-1221

Viewpoint

Dermatology Societies Should Explore Fossil Fuel Divestment

Abstract Full Text
has audio
JAMA Dermatol. 2022;158(10):1121-1122. doi:10.1001/jamadermatol.2022.3902

This Viewpoint describes the importance of dermatology societies and health care organizations divesting from fosile fuel investments to help mitigate the effects of climate change.

Editorial

Future Potential of 2-Photon Fluorescence Microscopy in Mohs and General Dermatology Practice

Abstract Full Text
JAMA Dermatol. 2022;158(10):1123-1124. doi:10.1001/jamadermatol.2022.3510

JAMA Dermatology’s Commitment to Diversity, Equity, and Inclusion

Abstract Full Text
free access
JAMA Dermatol. 2022;158(10):1125-1126. doi:10.1001/jamadermatol.2022.3970
Original Investigation

Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis

Abstract Full Text
free access
JAMA Dermatol. 2022;158(10):1131-1141. doi:10.1001/jamadermatol.2022.2909

This cohort study examines the drug survival associated with the effectiveness and safety of commonly used biologics for psoriasis in the UK and Ireland.

Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records

Abstract Full Text
open access
JAMA Dermatol. 2022;158(10):1142-1148. doi:10.1001/jamadermatol.2022.3142

This cohort study assesses generalized pustular psoriasis flares and their treatment, as well as differences between patients with and patients without flares documented in US electronic health records (EHRs).

Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual Level

Abstract Full Text
free access
JAMA Dermatol. 2022;158(10):1149-1156. doi:10.1001/jamadermatol.2022.3171

This cohort study used predictive modeling and machine learning to examine which biologic therapy for individual patients with psoriasis was associated with treatment retention.

Association Between Low-Dose Methotrexate Exposure and Melanoma: A Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA Dermatol. 2022;158(10):1157-1166. doi:10.1001/jamadermatol.2022.3337

This systematic review and meta-analysis assesses whether low-dose methotrexate exposure is associated with a higher risk of cutaneous melanoma.

Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders

Abstract Full Text
free access
JAMA Dermatol. 2022;158(10):1167-1174. doi:10.1001/jamadermatol.2022.3347

This case series evaluates a cohort of patients with subcutaneous panniculitis-like T-cell lymphoma and related conditions to characterize their clinical and pathological presentation, management, disease course, and outcome.

Real-time Analysis of Skin Biopsy Specimens With 2-Photon Fluorescence Microscopy

Abstract Full Text
open access
JAMA Dermatol. 2022;158(10):1175-1182. doi:10.1001/jamadermatol.2022.3628

This comparative effectiveness research study examines the ability of 2-photon fluorescence microscopy to capture characteristic nonmelanoma skin cancer features.

Brief Report

Quality and Perceived Usefulness of Patient-Submitted Store-and-Forward Teledermatology Images

Abstract Full Text
JAMA Dermatol. 2022;158(10):1183-1186. doi:10.1001/jamadermatol.2022.2815

This survey study examines the quality and perceived usefulness of patient-submitted dermatology images.

Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata

Abstract Full Text
JAMA Dermatol. 2022;158(10):1187-1191. doi:10.1001/jamadermatol.2022.3025

This cross-sectional survey study evaluates patient preferences for shared decision-making and its association with decisional regret.

Review

Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(10):1193-1201. doi:10.1001/jamadermatol.2022.3234

This systematic review informs a panel of 40 experts and patients to develop clinical practice guidelines for safe and effective use of laser-assisted drug delivery in various medical and cosmetic applications.

Images in Dermatology

Nail Sarcoidosis

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(10):1202. doi:10.1001/jamadermatol.2022.3255

This case report describes significant longitudinal ridging and nail plate crumbling on several of a patient’s fingernails.

Monkeypox Infection

Abstract Full Text
free access has active quiz
JAMA Dermatol. 2022;158(10):1203. doi:10.1001/jamadermatol.2022.3975

This case report describes multiple subcentimeter vesicles and papulovesicules with central necrosis surrounding the anal opening.

JAMA Dermatology Clinicopathological Challenge

A Rapidly Enlarging Facial Abscess

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(10):1205-1206. doi:10.1001/jamadermatol.2022.3756

A woman in her late 70s with a history of immunoglobulin A monoclonal gammopathy of unknown significance presents with a tender, draining lesion of the central face. What is your diagnosis?

Research Letter

Proton Pump Inhibitors Associated With Drug-Induced Lupus Erythematosus

Abstract Full Text
free access
JAMA Dermatol. 2022;158(10):1208-1210. doi:10.1001/jamadermatol.2022.2421

This descriptive case series investigates the potential association between the use of proton pump inhibitors and drug-induced lupus erythematosus in cases reported in 2 large pharmacovigilance databases.

Differences in Face-to-Face Time Spent With a Dermatologist Among Patients With Psoriasis Based on Race and Ethnicity

Abstract Full Text
free access
JAMA Dermatol. 2022;158(10):1210-1212. doi:10.1001/jamadermatol.2022.2426

This cross-sectional study examines whether a physician’s time spent with a patient with psoriasis differs based on the patient’s race and ethnicity.

Prevalence of Leukopenia and Associated Outcomes in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Abstract Full Text
free access
JAMA Dermatol. 2022;158(10):1212-1214. doi:10.1001/jamadermatol.2022.3011

This case series compares the factors, comorbidities, and complications associated with leukopenia between patients with and without leukopenia on hospital admission.

Neurofibromatosis Type 1 and Risk of Skin Cancer

Abstract Full Text
free access
JAMA Dermatol. 2022;158(10):1214-1216. doi:10.1001/jamadermatol.2022.3083

This cohort study examines the odds of developing basal cell carcinoma, squamous cell carcinoma, or melanoma among insured adults with neurofibromatosis type 1.

Observation

Cutaneous Herpetiform Ulcerations as the Presenting Sign of an Acute Aortic Occlusion

Abstract Full Text
JAMA Dermatol. 2022;158(10):1216-1218. doi:10.1001/jamadermatol.2022.2527

This case report describes a woman in her 40s with a 2-week history of abrupt painful ulcerations of the perineum.

Botulinum Toxin A for the Treatment of Yellow Nail Syndrome and Palmar Primary Hyperhidrosis

Abstract Full Text
JAMA Dermatol. 2022;158(10):1218-1219. doi:10.1001/jamadermatol.2022.2533

This case report describes a 23-year-old man with excessive sweating of the bilateral palms and 20 yellow nails.

Comment & Response

Why Increased Diversity in Dermatologic Clinical Trials Is Not Inherently Ethical—An Evidence-Based, Community-Engaged Approach to Diverse Trial Recruitment

Abstract Full Text
JAMA Dermatol. 2022;158(10):1219. doi:10.1001/jamadermatol.2022.3109

Comorbidities in Korean Patients With Palmoplantar Pustulosis vs Psoriasis Vulgaris or Pompholyx

Abstract Full Text
JAMA Dermatol. 2022;158(10):1220. doi:10.1001/jamadermatol.2022.3598

Comorbidities in Korean Patients With Palmoplantar Pustulosis vs Psoriasis Vulgaris or Pompholyx—Reply

Abstract Full Text
JAMA Dermatol. 2022;158(10):1220-1221. doi:10.1001/jamadermatol.2022.3595
Correction

Errors in Figure 2 and Table 3

Abstract Full Text
free access
JAMA Dermatol. 2022;158(10):1221. doi:10.1001/jamadermatol.2022.3698
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2022;158(10):1101. doi:10.1001/jamadermatol.2021.4229
×